K2LTS Telomerase Inhibitor by K2LT LAB, LLC 84429-002 Complete

K2LTS Telomerase Inhibitor by

Drug Labeling and Warnings

K2LTS Telomerase Inhibitor by is a Otc medication manufactured, distributed, or labeled by K2LT LAB, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

K2LTS TELOMERASE INHIBITOR- telomerase inhibitor liquid 
K2LT LAB, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

84429-002 Complete

Active Ingredient

ginsenoside 23%

Purpose

Indications: This drug is indicated for cancer patients, people with a family history of cancer, or people exposed to work with radioactivity.

Use

Product Benefits: This product can inhibit the activity of telomerase, thus preventing the proliferation and growth of tumor cells;

Warnings

This product should not be used in combination with antibiotics;

Do not use

This product should not be used in patients who are allergic to any component of this product;

When Using

Precautions: Combined use with other drugs or increased exposure to this product may result in clinically significant adverse reactions. Combined use with other drugs may significantly decrease the concentration of this product, leading to decreased therapeutic effect of the drug combination.

Stop Use

If there is any discomfort during use, please discontinue this product.

Ask Doctor

If the patient has any underlying medical condition, please consult the doctor before taking this product.

Keep Oot Of Reach Of Children

Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

Directions

Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.

Other information

Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.

Inactive ingredients

EGCG Sulforaphane cordycepin Ergothioneine Selenium Sodium benzoate

PRINCIPAL DISPLAY PANEL

K2LTS TELOMERASE INHIBITOR 
telomerase inhibitor liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84429-002
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GINSENOSIDES (UNII: 3K198YD54P) (GINSENOSIDES - UNII:3K198YD54P)	GINSENOSIDES	23 g  in 100

Inactive Ingredients
Ingredient Name	Strength
SELENIUM (UNII: H6241UJ22B)
CORDYCEPIN (UNII: GZ8VF4M2J8)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SULFORAPHANE (UNII: GA49J4310U)
ERGOTHIONEINE (UNII: BDZ3DQM98W)
EPIGALLOCATECHIN GALLATE (UNII: BQM438CTEL)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84429-002-01	20 in 1 BOX; Type 0: Not a Combination Product	06/20/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		06/20/2024	01/28/2026

Labeler - K2LT LAB, LLC (072189878)

Establishment
Name	Address	ID/FEI	Business Operations
K2LT LAB, LLC		072189878	manufacture(84429-002)

Revised: 1/2026

Document Id: 496a0200-4d3a-cde3-e063-6294a90a897f

34390-5

Set id: 1b4daf1d-a7a5-8fd1-e063-6294a90a817e

Version: 3

Effective Time: 20260127